Summary: ACE inhibitors, ARBs, or both for hypertension and proteinuria; an interview with Dr. Patrick Parfrey of Memorial University in Newfoundland Canada on the risks of combining ACE inhibitors and ARBs; risperidone for major depression; a new ACP practice guideline on the diagnosis and management of stable chronic obstructive pulmonary disease; and other highlights of this week's issue.
